Cannabis Stocks Rally to 2024 Highs on Policy Momentum

Cannabis equities delivered their strongest weekly performance of 2024, with major operators and MSOs posting double-digit gains as regulatory momentum builds ahead of key policy decisions. The sector-wide rally marks a sharp reversal from months of subdued trading, with institutional money flowing back into names that have traded at steep discounts to traditional retail and consumer goods companies.

The surge comes as federal rescheduling discussions gain traction and state-level expansion continues across key markets. Multi-state operators with strong balance sheets and diversified geographic footprints led the charge, benefiting from renewed investor confidence in the regulatory pathway forward. Trading volumes spiked across the board, suggesting institutional participation rather than retail-driven momentum that characterized previous cannabis rallies.

Valuation multiples remain compressed compared to other consumer discretionary sectors, creating potential upside as regulatory clarity emerges. Companies with strong cash positions and operational efficiency metrics attracted the most attention, while heavily leveraged operators lagged despite the overall sector strength. The performance gap highlights investor focus on fundamentals rather than pure momentum plays.

The rally reflects growing institutional comfort with cannabis exposure as banking restrictions ease and compliance frameworks mature. Professional investors who previously avoided the sector due to federal uncertainty now view select operators as viable long-term holdings, particularly those with strong state-level market positions and proven execution capabilities.

Sustaining this momentum requires continued regulatory progress and strong quarterly results from leading operators. The sector faces critical earnings reports in coming weeks that will test whether operational improvements can justify current valuations and support further institutional adoption across cannabis equities.